Plain-English translation of NCT07282743 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called GL0034 to see if it can help people with type 2 diabetes who are overweight or obese control their blood sugar levels better. You would receive the medication as a weekly injection under your skin over about a year, while researchers measure how well it works and whether it's safe.
Many people with type 2 diabetes struggle to reach their blood sugar goals, especially if they are also overweight or obese. This medication is being tested to see if it can help fill that gap and offer a new treatment option beyond current diabetes medications.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic multiple times over about 12 months. First, you'd gradually increase your dose over approximately 20 weeks, then continue at a steady dose for another 28 weeks. Each week you'd give yourself an injection under your skin, and you'd check your blood sugar at home on certain days using a device provided by the study. The main goal is to see how the medication affects your blood sugar levels compared to those who receive a placebo (dummy injection).
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
United States